Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for graft function after deceased donor kidney transplantation
ChiCTR1900025493Phase 4Completed
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in end-stage kidney disease (ESKD) comparing Dexmedetomidine with Placebo (2 arms). Primary endpoint: Incidence of delayed graft function. Started Sep 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on ChiCTR1900025493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025493.